SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program

Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems

Intel VP: “We’re just not going to accept subpar products”

Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff

Buzz

Most popular

Daily

Weekly

1

“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals

2

Nice puts Actimize up for sale at a $1.5-2 billion price tag

3

Cybereason founders' 7AI raises record $130 million Series A in breakneck rise

4

Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers

5

Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ

Glaucoma

4 stories about Glaucoma

מיכאל בלקין מוסף

The 83-year-old who sold his invention for $466 million, and still walks to work every morning

14.08.25|Roni Dori

Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.

דריה להמן-בלומנטל

The Israeli startup treating the silent thief of sight

30.01.22|Yafit Ovadia

BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness

דריה למאן בלומנטל מנכ״ל ארגון בלקין לייזר

Belkin Laser announces $12.2 million raised in series B funding

21.07.20|Hagar Ravet

The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years

BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer

The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange